Research News and Research

RSS

Higher intake of vitamin K from dietary sources associated with lower risk of Non-Hodgkin lymphoma

In the first study of vitamin K and Non-Hodgkin lymphoma risk, researchers at the Mayo Clinic campus in Minnesota have found that people who have higher intakes of vitamin K from their diet have a lower risk of developing Non-Hodgkin lymphoma.

20 Apr 2010

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

19 Apr 2010

OECs may hold promise for pediatric cerebral palsy treatment

A unique cell type that supports and surrounds (ensheathes) neurons within the nose (olfactory system) known as olfactory ensheathing cells (OECs), possess the ability to regenerate, are relatively easy to obtain, and have become prime candidates for transplantation to repair a number of lesions in the central nervous system (CNS).

19 Apr 2010

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.

19 Apr 2010

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.

19 Apr 2010

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

Magen Medical Solutions Ltd., a medical device company developing unique anti-adhesion devices for orthopedic applications, is pleased to announce that it has successfully implanted its first product, the SpineShield, in three patients at a clinical site in Europe.

19 Apr 2010

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

NanoImaging Services, Inc., announced today that it has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health through the National Center for Research Resources to develop new methods for quantitative characterization of nanoparticle morphology and aggregation state using transmission electron microscopy. The grant provides approximately $200,000 in research and development funds for a Phase I study.

19 Apr 2010

Myriad Pharmaceuticals terminates merger agreement with Javelin Pharmaceuticals

Myriad Pharmaceuticals, Inc. today announced the termination, effective as of Friday, April 16, 2010, of its merger agreement with Javelin Pharmaceuticals.

19 Apr 2010

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported the development of a novel protein complex, designated as E1-L-thP1, for targeted delivery of small interfering ribonucleic acids (siRNAs) to diverse solid cancers.

19 Apr 2010

Affinion Security Center enhances BreachShield service

Affinion Security Center, a leading provider of identity theft protection services, today announced enhancements to its BreachShield(SM) service, aimed at preventing, detecting and resolving Identity Theft resulting from data breaches for companies at risk and the consumers who trust those organizations. The new enhancements are designed for all types of organizations that experience a breach and include benefits that help customers at risk for medical identity theft.

19 Apr 2010

Biomarkers to help predict development of aggressive colorectal cancer discovered

Researchers at the University of Alabama at Birmingham (UAB) Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

19 Apr 2010

PRA International expands clinical research operations to New Zealand

PRA International, a leading Clinical Research Organization, announces it has established a legal entity and hired staff in New Zealand, which will complement the firm's extensive network of Asia-Pacific operations and partnerships.

19 Apr 2010

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today announced the Quantum FX, a stand-alone microCT system for preclinical imaging. Introduced at the American Association for Cancer Research Annual Meeting 2010, the Quantum FX is a low dose, microCT system that provides researchers with a 3-dimensional anatomical view of disease activity, tumor development and therapeutic response over multiple time points during the course of a study.

19 Apr 2010

Alere director to analyze value of worksite health programs at 28th SALGBA conference

The importance of measuring productivity, short-term disability, workers' comp and job satisfaction when analyzing the value of worksite health programs will be the key focal points of a presentation by David Wolf, MBA, director of product management for Alere, at the 28th annual State and Local Government Benefits Association (SALGBA).

19 Apr 2010

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Medical experts from across the UK are gathering at the University of Leicester on Friday 23rd April in a Valedictory Symposium to celebrate the work of Professor David Taylor.

19 Apr 2010

Study finds impact of free prescriptions on dispensing rates minimal

The overall impact of free prescriptions on dispensing rates in Wales has been minimal according to research conducted by academics at the University of Glamorgan in collaboration with colleagues at Cardiff and Bangor Universities.

19 Apr 2010

Amylin Pharmaceuticals announces $174.1M total revenue for first-quarter 2010

Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010. The Company reported total revenue of $174.1 million for the quarter ended March 31, 2010, which includes net product sales of $172.3 million. Non-GAAP operating loss was $3.8 million for the quarter ended March 31, 2010, compared to $19.9 million for the same period in 2009.

19 Apr 2010

Healthyroads announces new partnership status with NAQC

Healthyroads, the wellness subsidiary of American Specialty Health Incorporated, announced its new partnership status with the North American Quitline Consortium and its approval to serve as an authorized quitline vendor in the state of Michigan.

19 Apr 2010

First authoritative book on yawning

Yawning is a stereotyped phylogenetically ancient phenomenon that occurs in almost all vertebrates. As an emotional behavior and an expressive movement, yawning has many consequences; nevertheless, it has so far been poorly addressed in medical research and practice.

19 Apr 2010

Investment report on Generex Biotechnology from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

19 Apr 2010

Research News and Research

Higher intake of vitamin K from dietary sources associated with lower risk of Non-Hodgkin lymphoma

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

OECs may hold promise for pediatric cerebral palsy treatment

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

Myriad Pharmaceuticals terminates merger agreement with Javelin Pharmaceuticals

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Affinion Security Center enhances BreachShield service

Biomarkers to help predict development of aggressive colorectal cancer discovered

PRA International expands clinical research operations to New Zealand

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Alere director to analyze value of worksite health programs at 28th SALGBA conference

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Study finds impact of free prescriptions on dispensing rates minimal

Amylin Pharmaceuticals announces $174.1M total revenue for first-quarter 2010

Healthyroads announces new partnership status with NAQC

First authoritative book on yawning

Investment report on Generex Biotechnology from MicroStockProfit.com

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News